The Jacques and Gloria Gossweiler Foundation presents the Neurology Research Grant 2026:
The Jacques and Gloria Gossweiler Foundation offers a "Neurology Research Grant" to support high quality research on non-pharmacological treatment of symptoms experienced by patients with Parkinson's disease and other movement disorders performed in a research center in or related to Switzerland. The principal applicant must be able to carry out the research project under his own responsibility. The applicant must be able to show that he/she is employed at least 50% for the duration of the project at a research institution, with the necessary research infrastructure.
The funding period is two years, with a possible extension up to a maximum of 4 years. lt includes any support of the research project, with the exception of the applicant's own salary.
Application deadline: 30. September 2026
This is the most important starting point.
JGGF's stated medical-research purpose is to support projects in hematology and neurology.
Particularly relevant neurological areas include:
Funded examples include research in Parkinson's disease, Huntington's disease, gait rehabilitation, anxiety in Huntington's disease, dystonia and cerebellar dysfunction.
Hematology is another explicit JGGF research field, with a dedicated Hematology Research Grant for projects performed at a research center in Switzerland.
JGGF's philosophy is particularly distinctive here.
The Foundation states that it supports projects that do not receive sufficient support from public or private sources, for example because of political considerations, small patient populations, or other funding limitations.
Therefore, a strong proposal should explain:
Why is this important research currently underserved?
This is especially compelling when the disease is:
JGGF describes its Neurology Research Grant as supporting high-quality research into symptoms experienced by people with Parkinson's disease and other movement disorders.
Competitive applications should therefore have:
For neurological research, JGGF has a particularly strong history of supporting studies aimed at improving symptoms and functioning, rather than exclusively investigating disease biology.
Examples include:
For example, JGGF supported the Exercise Rehabilitation Trial in Huntington's Disease (ExeRT-HD), a randomized controlled trial evaluating aerobic and strengthening exercise.
This suggests a strong fit for research where the pathway is:
Neurological disorder → important symptom → intervention → measurable improvement in function/quality of life
This is particularly important for the Neurology Research Grant.
The current description specifically identifies research on non-pharmacological treatment of symptoms experienced by patients with Parkinson's disease and other movement disorders.
Strong areas therefore include:
This is an important distinction: a purely pharmaceutical Parkinson's drug-development project would be much less aligned with this particular grant.
For the Neurology Research Grant, the principal applicant must be able to conduct the research under their own responsibility. The applicant must also demonstrate at least 50% employment for the duration of the project at a research institution with the necessary infrastructure.
Therefore, strong applications demonstrate:
This criterion can be decisive even when the science itself is strong.
For the Neurology Research Grant, the research must be conducted at a research center in or related to Switzerland.
The Hematology Research Grant similarly supports hematology research conducted at a research center in Switzerland.
Thus:
Swiss institutional eligibility + appropriate infrastructure + qualified investigator
is a fundamental grant-fit requirement.
JGGF-funded research demonstrates a strong interest in research that can eventually improve patient care.
Examples include:
JGGF-funded Huntington's disease research has included feasibility trials of psychological interventions and community-based physical exercise.
A proposal becomes stronger when it explains:
Research finding → practical intervention → patient benefit
JGGF's grant structure favors projects that can be completed within a defined period.
The Neurology Research Grant has a two-year funding period, with a possible extension to a maximum of four years.
The proposal should therefore demonstrate:
A small but rigorously designed movement-disorder trial may therefore be stronger than an excessively ambitious project.
This is a distinctive JGGF advantage.
The Foundation explicitly recognizes that certain projects may struggle to receive conventional funding because of small populations or limited financial/medical resources.
This creates particularly good potential alignment with:
The Foundation has in fact supported Huntington's disease research involving exercise, psychological interventions and wearable monitoring.
The principal applicant must be able to carry out the research project under his own responsibility. The applicant must be able to show that he/she is employed at least 50% for the duration of the project at a research institution, with the necessary research infrastructure.
Eligible Countries:
Sponsor Institute/Organizations: Jacques and Gloria Gossweiler Foundation
Sponsor Type: Corporate/Non-Profit
Address: Breite Gasse 4/7 1070 Vienna
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Sep 30, 2026
Sep 30, 2026
Varies
varies
Affiliation: Jacques and Gloria Gossweiler Foundation
Address: Breite Gasse 4/7 1070 Vienna
Website URL: https://www.ean.org/research/programmes-and-funding/by-other-organisations
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.